Announced Tue, 23 Jun · 18:28 IST
CRISIL upgrades Solara Pharma credit rating to BBB+/Stable
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.5%1-day move
₹578.75
prior close
₹584.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.5+2.3+2.4+1.7-1.5-1.0-0.2-2.1-0.9-3.3-0.5-14.6——
Up moveDown movePending
AI summary
CRISIL upgraded Solara Active Pharma's credit ratings on its Rs 791.2 crore bank loan facilities. Long-term rating moved up from BBB/Stable to BBB+/Stable, and short-term rating improved from A3+ to A2. The upgrade covers cash credit, letters of credit, and term loans across banks including HDFC, ICICI, IDFC FIRST, YES Bank, and RBL Bank.
Likely market impact
Positive signal on financial health; may lower future borrowing costs and is supportive for the stock.